Type II restriction endonuclease BtgZI, obtainable from Bacillus thermoglucosidasius 36A and a process for producing the same
AssigneeNew England Biolabs, Inc.
InventorsRichard D. Morgan, Paul Walsh
Life of this patent
Estimating the term…
Loading patent…
AssigneeNew England Biolabs, Inc.
InventorsRichard D. Morgan, Paul Walsh
Estimating the term…
In accordance with the present invention, there is provided a novel restriction endonuclease obtainable from Bacillus thermoglucosidasius 36A (NEB#1384), hereinafter referred to as “BtgZI”, which endonuclease: (1) recognizes the nucleotide sequence 5′-GCGATG-3′ in a double-stranded DNA molecule as shown below, 5′-GCGATGNNNNNNNNNN↓-3′ (SEQ ID NO:9) 3′-CGCTACNNNNNNNNNNNNNN↑-5′ (wherein G represents guanine, C represents cytosine, A represents adenine, T represents thymine and N represents either G, C, A, or T); (2) cleaves said sequence in the phosphodiester bonds between the 10th and the 11th nucleotides 3′ to the recognition sequence in the 5′-GCGATG-3 strand of the DNA, and between the 14th and 15th nucleotides 5′ to the recognition sequence in the complement stand, 5′-CATCGC-3′, to produce a 4 base 5′ extension; and (3) cleaves double-stranded pBR322 DNA to produce 3 fragments of 2892, 1181 and 288 base pairs.
A substantially pure Type II restriction endonuclease obtainable from Bacillus thermoglucosidasius 36 A (ATCC Accession No. PTA-6692) recognizing the following base sequence in double-stranded deoxyribonucleic acid molecules:
Dependencies are inferred from the claim text.